|
BMS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.914000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.336200E-01 |
| Normal-vs-Stage2 |
7.656200E-02 |
| Normal-vs-Stage3 |
1.602510E-03 |
| Normal-vs-Stage4 |
6.426300E-02 |
| Stage1-vs-Stage2 |
1.717790E-01 |
| Stage1-vs-Stage3 |
2.044500E-03 |
| Stage1-vs-Stage4 |
1.996170E-01 |
| Stage2-vs-Stage3 |
4.309400E-01 |
| Stage2-vs-Stage4 |
8.133000E-01 |
| Stage3-vs-Stage4 |
2.189200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.359600E-02 |
| Normal-vs-AfricanAmerican |
4.103600E-01 |
| Normal-vs-Asian |
5.026200E-01 |
| Caucasian-vs-AfricanAmerican |
3.359600E-01 |
| Caucasian-vs-Asian |
1.744410E-01 |
| AfricanAmerican-vs-Asian |
3.491400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.764300E-03 |
| Normal-vs-Female |
5.336400E-01 |
| Male-vs-Female |
4.918300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.435800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.148200E-02 |
| Normal-vs-Age(61-80Yrs) |
4.259900E-02 |
| Normal-vs-Age(81-100Yrs) |
2.656600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.452000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.345200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.977200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.143400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.501400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.692000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.357600E-02 |
| Normal-vs-Grade 2 |
2.430400E-01 |
| Normal-vs-Grade 3 |
5.255500E-03 |
| Normal-vs-Grade 4 |
7.918300E-02 |
| Grade 1-vs-Grade 2 |
3.253700E-02 |
| Grade 1-vs-Grade 3 |
3.003600E-03 |
| Grade 1-vs-Grade 4 |
2.060000E-02 |
| Grade 2-vs-Grade 3 |
2.710100E-02 |
| Grade 2-vs-Grade 4 |
3.491000E-01 |
| Grade 3-vs-Grade 4 |
5.327200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.396800E-01 |
| Normal-vs-ccB subtype |
3.938800E-03 |
| ccA subtype-vs-ccB subtype |
8.278300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.547700E-02 |
| Normal-vs-N1 |
6.926000E-01 |
| N0-vs-N1 |
1.325220E-01 |
|
|
